Record revenues from clinical research for Israel medical centers in 2012: 370 million NIS. The scale of clinical trials in 2012 jumped at Beilinson and Sheba hospitals, and revenues amounted to more than 60 million NIS. Quintiles clinical trials company invested last year the largest amount in Israel – 29.8 million NIS. Teva invested 5.1 million - 40% less than in 2011 (Hebrew).
April 10: Life Sciences Panel – Making it in NYC. Israel and New York City enjoy a close relationship founded on long-standing economic and cultural ties. On Wednesday, April 10th, representatives from NYC’s Life Sciences sector will discuss opportunities for Israeli companies and organizations to partner with NYC-based companies, organizations and Academic Medical Centers.
IATI-BIOMED June 10-12 to be Crowd-Driven. The Israel Advanced Technology Industry (IATI) is taking the innovation conversation to the next level at its 12th annual IATI-BioMed Conference, and is inviting participants to take the stage and present their latest, most cutting edge developments in Life Sciences to date. For the first time ever, Israeli and international Biomed companies, scientists and entrepreneurs will be given the Chance-To-Speak and present their latest innovations at the IATI BioMed Conference, simply by submitting a 200 word abstract on the topic they wish to showcase.